Moderna collaborates with Thermo Fisher to produce at scale

Posted 23 February, 2022

Moderna and life sciences company Thermo Fisher Scientific has entered into a long-term agreement to collaborate on large-scale manufacturing of the Covid-19 vaccine and other therapies based on its mRNA technology. The two companies have previously worked together to support Moderna's pipeline, with Thermo Fisher providing clinical research and manufacturing services, including aseptic fill and finish services and Covid vaccine packaging.

The expanded agreement will allow them to offer capabilities for other fill-finish services and provide inspection, labeling, and final packaging services. 

Previous story

23 February, 2022 16:19

← Methane emissions largely underestimated, warns the IEA

Methane emissions from the energy sector are largely underestimated in official statements, alerted the International Energy Agency (IEA) on Wednesday, which calls for action against this powerful greenhouse gas to fight against the climate deregulation.

Methane emissions largely underestimated, warns the IEA

Next story

23 February, 2022 09:42

Member of the Bundestag: decision on Nord Stream 2 is not final →

Head of the Bundestag committee Ernst: decision on Nord Stream 2 is not final

 

Member of the Bundestag: decision on Nord Stream 2 is not final
Write a comment
 
Prove you’re not a bot + 6 = 25